Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
about
Bisphosphonate therapy for children and adolescents with secondary osteoporosisConsequences of irradiation on bone and marrow phenotypes, and its relation to disruption of hematopoietic precursorsAltered composition of bone as triggered by irradiation facilitates the rapid erosion of the matrix by both cellular and physicochemical processesRelative osteopenia after treatment for acute lymphoblastic leukemia.Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhoodAlendronate for steroid-induced osteopenia in children with acute lymphoblastic leukaemia or non-Hodgkin's lymphoma: results of a pilot study.Osteoporosis resulting from acute lymphoblastic leukemia in a 7-year-old boy: a case report.High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapyBone morbidity in childhood leukemia: epidemiology, mechanisms, diagnosis, and treatmentOsteoporosis in childhood: bone density of children in health and disease.Bone mineral density deficits and fractures in survivors of childhood cancer.Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study.Body composition and bone health in long-term survivors of acute lymphoblastic leukaemia in childhood and adolescence: the protocol for a cross-sectional cohort studyImpairments that influence physical function among survivors of childhood cancerSkeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemiaThe impact of inflammation on bone mass in children.Reduced bone density at completion of chemotherapy for a malignancyThe impact of corticosteroids on growth and bone health.Vitamin D protects acute lymphoblastic leukemia cells from dexamethasonePotential Effects of Phytoestrogen Genistein in Modulating Acute Methotrexate Chemotherapy-Induced Osteoclastogenesis and Bone Damage in Rats.Vitamin D and Bone Minerals Status in the Long-term Survivors of Childhood Acute Lymphoblastic Leukemia.Bone mineral density change during adjuvant chemotherapy in pediatric osteosarcomaBone turnover in long-term survivors of childhood acute lymphoblastic leukemia.Fractures among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.Aggravated bone density decline following symptomatic osteonecrosis in children with acute lymphoblastic leukemiaBone mineral density deficits in childhood cancer survivors: Pathophysiology, prevalence, screening, and management.Early injury to cortical and cancellous bone from induction chemotherapy for adolescents and young adults treated for acute lymphoblastic leukemiaLongitudinal assessment of bone density and structure in childhood survivors of acute lymphoblastic leukemia without cranial radiationEndocrinological and cardiological late effects among survivors of childhood acute lymphoblastic leukemia.Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research programMethotrexate toxicity in growing long bones of young rats: a model for studying cancer chemotherapy-induced bone growth defects in children.Drug-vitamin D interactions: a systematic review of the literatureThe Incidence of and Factors Associated with Vitamin D Deficiency in Newly Diagnosed Children with Cancer.Childhood cancer chemotherapy-induced bone damage: pathobiology and protective effects of resveratrol and other nutraceuticals.Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic LeukemiaOsteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.Low bone mass in children with malignant lymphoma.Bone health in children and adolescents with steroid-sensitive nephrotic syndrome assessed by DXA and QUS.Evaluation of bone mineral density at different phases of therapy of childhood all.Bone mineral density in children with acute lymphoblastic leukemia.
P2860
Q24243298-B734D222-B4BD-4255-886F-7AADA4037EFFQ26864483-32FF1144-DFCC-4466-8673-AF8DF023F03FQ28533498-0C6DB7D4-B8E8-4355-9EE0-46B9E350FA42Q30670818-CC6388C9-838F-4EA6-9F5A-8CA1A2DFA1AEQ30671116-F50D6A89-0236-4EC1-8871-2FEF6498D14AQ33233193-2A3F26E1-0BE4-4D20-9486-B81DBB86E42CQ33415652-DA3C3BB1-C507-4983-A041-34112B131692Q33618291-7D513E5D-2D01-423B-91E4-4AD581BB3649Q34038283-9A608314-4DC2-4E70-BFC7-3D235EB69FA8Q34342546-04D7DE42-97C6-48CD-A7C3-052B73C626D0Q34660950-FFCD5D85-442F-4E58-A0C5-26C365E8ACA3Q34989434-32424CFE-2A7D-4A44-A210-5FA60CA49493Q35008177-B872E269-CDE2-4CE7-8BF5-76CD11C09BF5Q35082766-1AE51544-A984-46D0-BFCE-15B2299BE040Q35106981-0C09C6C2-88A5-46EF-8F61-45E918C93991Q35226354-3E3C0995-577F-4175-B2E3-781AFE664404Q35262328-B2152DF4-D5EB-4FFA-8EEA-94DD6EB66C3DQ35273301-992D536B-3D28-493C-A4FF-D290F31EF3C6Q35854591-37EE9D6C-0B5C-4EED-BEE8-CD4223CDD879Q36088558-1D0E8357-EE81-425D-B5AF-BE79194C5CA9Q36103622-524E6242-CE4B-423C-82AC-4B3030C5FA8DQ36215768-8CB9BF3F-68D1-44D8-942E-760BDC554E95Q36224114-ABE9EA8B-36B4-424D-B081-E3FBA668E41FQ36227560-866300AA-8C83-4CAB-82F4-0D183B527977Q36337592-EF48E565-7F34-41BE-8AE0-B0616F50AB06Q36660326-55322A58-2786-4298-9527-EA8AAC2CBEBEQ36697564-2E4903B6-3750-40E0-A0FA-C3BE33BA08E3Q36906942-0F43DD42-0F7F-4C8F-AEA9-214FA1E6EEBFQ37426570-788B3D21-EF4D-4809-9795-037551FC28BAQ37473111-EA83731B-6FAB-459A-B6F1-8B0AE0F65A6AQ37871863-FBFB245D-AF62-4A6C-810A-0EB9EBA86B12Q38073239-E01A11A4-2551-4055-9CBA-3C28F4547D61Q38857203-3BFB52CD-13B7-4083-AE4A-2C0720638D56Q39405101-5AD9C7EE-A443-417E-97B8-BC3F8BB5FFF9Q42072301-ECEB6245-B0DC-4F77-80CE-C61D895551FBQ44063029-89DE83DE-3ACD-489F-AC2C-EE05B37F151CQ46278585-A51A86BD-A340-4EEA-87C2-EFCA30D302F2Q46284598-E64CCEE6-D04C-4342-BE56-42ECBD6EFFBCQ46834698-0491669E-424C-4FFF-8CF0-3EC4395C74E3Q47269821-475B40AE-71AF-4BA2-8690-FAABB3FA70A4
P2860
Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Altered mineral metabolism and ...... acute lymphoblastic leukemia.
@en
type
label
Altered mineral metabolism and ...... acute lymphoblastic leukemia.
@en
prefLabel
Altered mineral metabolism and ...... acute lymphoblastic leukemia.
@en
P2093
P356
P1476
Altered mineral metabolism and ...... acute lymphoblastic leukemia.
@en
P2093
Atkinson SA
P2860
P304
P356
10.1002/JBMR.5650111122
P577
1996-11-01T00:00:00Z